patients and pharma

Vitamin supplements and apple

Supplement safety smarts

It’s easy to see the temptation of taking dietary supplements. Getting vitamins, minerals and herbs or other “health foods” in pill form sounds simple. And some of the products’ claims — “Live longer!” or “Have more energy!” — may seem enticing. But even though most supplements don’t require a prescription, it’s best to check with your doctor before taking them because they may come with risks — read on to learn more. Healthy intentions The BBC recently highlighted the potential risks in a piece called “The food supplement that ruined my liver.” As Texas resident Jim McCants recalls, he was hitting age 50 and hoping to prevent the heart problems that his father died from, so he sought to make some lifestyle changes. These included taking a green tea supplement, which wound up damaging the Texas resident’s liver so badly that he needed a transplant. Years later, McCants still struggles with kidney disease and abdominal pain — all because of a product he thought would make him healthier. McCants isn’t alone. More than 50% of U.S. adults take a dietary supplement, often in the form of multivitamins, calcium, folic acid or vitamin D. And supplements are nothing new. The Chinese have been …

Supplement safety smarts Read More »

Drug Safety: It’s About More Than Just Compliance

Engaging in social media presents a number of uncertainties to pharmaceutical companies. In a world where much of the medical dialog has moved online, these uncertainties have emerged due to absent or unclear guidelines from the Federal Drug Administration (FDA), privacy and regulatory concerns about engaging directly with patients, and the potential for significant consequences. When I recently spoke before the FDA, we highlighted how our pharmaceutical partners are taking a leadership role by navigating through these issues. In so doing, our partners are learning about real world experiences of patients and how to meet their adverse event reporting responsibilities in the PatientsLikeMe Epilepsy, Organ Transplant and Multiple Sclerosis communities. “…as the FDA contemplates the Internet and social media as an emerging source of drug safety data, it is essential to consider what characteristics distinguish a social media site as being capable of contributing to drug safety in a meaningful, computable and quantifiable manner.” Meaningful, computable and quantifiable are three words that underscore all that we do at PatientsLikeMe. This includes the creation of our patient safety program. Early on, we approached patient safety proactively with a pilot program in our Multiple Sclerosis Community. Launched in 2009, this program allows …

Drug Safety: It’s About More Than Just Compliance Read More »

Scroll to Top